Takeda Pharmaceutical Company Limited
T-CELL RECEPTOR MODIFIED OBJECT
Last updated:
Abstract:
The present invention provides a variant of a T-cell receptor containing a combination of two polypeptides containing a constant region of a T cell receptor chain selected from the group consisting of .alpha. chain, .beta. chain, .gamma. chain and .delta. chain, wherein the polypeptide does not contain a complementarity determining region (CDR) of the T cell receptor chain, a complementarity determining region (CDR) of the .alpha. chain, and a complementarity determining region (CDR) of the .beta. chain.
Status:
Application
Type:
Utility
Filling date:
26 Dec 2019
Issue date:
24 Mar 2022